All
RSSArticles
-
Diverse Populations Joining NIH All of Us
Nearly a quarter of a million people have joined the National Institutes of Health’s ambitious All of Us precision medicine initiative — with a large response from racial and ethnic minorities who have been historically victimized or ignored by human research.
-
Infectious Disease Alert Updates
California Inmates With Cocci Lose Appeal; Tuberculosis Testing in Small Children
-
Omadacycline (Nuzyra)
Omadacycline was approved in 2018 by the U.S. Food and Drug Administration (FDA) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
-
Histoplasmosis — Expansion of Risk Areas and Need for More Standardized Practice
Histoplasmosis is increasingly seen beyond the previous risk areas of the Ohio and Mississippi River valleys. Diagnostic and treatment practices vary widely.
-
Should IRBs Set an Incentive Pay Limit?
Not all IRBs and research institutions specifically address limits to how much researchers can compensate study participants. But allowing these limits to default to what is reportable to the IRS as income could be a mistake, one IRB chair says.
-
Vancomycin for MRSA Pneumonia Following Influenza in Children
Coinfection with methicillin-resistant Staphylococcus aureus (MRSA) in children with influenza is associated with high fatality. Data support the addition of a second anti-MRSA antibiotic to vancomycin in severely ill children.
-
Is Fecal Microbiota Transplantation Superior to Fidaxomicin for Recurrent Clostridioides difficile Infection?
In a randomized clinical trial, researchers found the combination of oral vancomycin followed by fecal microbiota transplantation was superior to treatment with fidaxomicin or vancomycin alone for patients with recurrent Clostridioides difficile infection.
-
Electronic Informed Consent Platform Enhances Education and Engagement
Since Memorial Sloan Kettering Cancer Center implemented the electronic informed consent process, thousands of research participants have consented electronically, increasing at a rate of about 500 per month.
-
A Half-Century Later, Guatemala Experiments Still Horrify
Bioethicists recently published a case study of this horrific chapter in human research history after comprehensively reviewing all the records of the Guatemala experiments. The most egregious aspect was that some participants were intentionally infected with syphilis and other STDs.
-
Microsoft Breach Reveals Risk From Cloud-Based Data Storage
A recent attack on email servers at Microsoft raises questions about the security of protected health information on servers that healthcare organizations use.